National Cancer Genetics MDT

The National Cancer Genetics MDT (UKCGG National CGM) is a collaboration between the CanGene-CanVar Programme and the UK Cancer Genetics Group (UKCGG), which aims to create a regular national forum to discuss complex cancer genetics cases, improve patient management and expand clinical knowledge. 

 

For patient confidentiality and clinical governance, meeting attendees will be required to register for the meeting in advance and are required to work within the NHS in the area of cancer genetics.

National Cancer Genetics MDT Objectives:

  1. Creation of a national multidisciplinary professional network and regular forum to discuss and advise on complex cancer genetics cases.

  2. Improve outcomes and consistency of care for patients by facilitating multidisciplinary discussion.

  3. Identify areas in which national guidelines are required or need updating.

  4. Improve training and education in clinical cancer genetics.

  5. Facilitate relevant publications in peer-reviewed journals based on cases discussed, best practice guidelines and the value of a national forum for clinicians and patients. 

Next Meeting

20 May 2021

@ 12:30pm

Agenda

  • Mixed cases

 

Register for the meeting

CGG logo.jpg

If you are a member of the British Society for Genetic Medicine (BSGM) and are interested in becoming part of the UKCGG, please click here for more information. 

Please see our UKCGG National CGM resources below for an up-to-date list of meeting summaries, educational tools, references and web-based links. 

Register to attend the next MDT

You must register in advance for this meeting

For patient confidentiality and clinical governance, meeting attendees will be required to register for the meeting in advance and are required to work within the NHS in the area of cancer genetics - please ensure that you register with your full name and NHS or academic email

 

Mixed Cases 
Thursday May 20th 12.30-13.45

Please register via the following link:

https://the-icr.zoom.us/meeting/register/u50qc-6hrTkvE9z0JDqOs_dwXMdCFNhs2msk 

 After registering, you will receive a confirmation email containing information about joining the meeting.

 
 

National Cancer Genetics MDT Format

​Bi-monthly 60-75 minute MDT via Microsoft Teams (with the possibility to increase this to monthly)​

Current time slot: 12:30-13:45, 3rd Thursday of the month, starting 15th October (to review future dates and alter if required)

Ground rules for the meeting will be circulated to all attendees

MDT to alternate between:

  • Expert topic - Short presentation by an invited expert and then discussion of 3-4 cases relevant to that specific topic

  • Mixed cases - Approx. 6 cases to include a mixture of cases where a clinical decision is required and "known" cases highlighting a specific learning point

Cases to be submitted in advance of the meeting using a set slide format clearly stating clinical questions or learning points

Cases which involve variant classification should be discussed in Can-VIG

Cases which involve significant ethical issues/debates should be discussed in GenETHICS

There will be nominated session Chair (Consultant in Cancer Genetics/Senior GC) which can be rotated through different centres

CPD accreditation (RCP) if possible

The Chair will select the cases for discussion and run the meeting with the help of an additional person to minute discussions and agreed actions

At least one representative from each centre should attend

Resources

Created by Helen Hanson, Anju Kulkani, Fiona Lalloo and Marc Tischkowitz on behalf of UKCGG Council and CanGene-CanVar.

UKCGG National CGM Information 
Last updated: 17 September 2020

An outline of the UKCGG National Cancer Genetics MDT meeting objectives and format.

 

UKCGG National CGM Presentation
(Antonis Antoniou - CanRisk: Breast and Ovarian Cancer Risk Prediction) 
Meeting date: 18 March 2021 
*NEW RESOURCE 

Presentation slides from Prof Antonis Antoniou, Professor of Cancer Risk Prediction, Department of Public Health and Primary Care, University of Cambridge

UKCGG National CGM Presentation
(Exponent scoring system for variant classification) 
Meeting date: 11 February 2021
 

Presentation slides from Dr Alice Garrett, Clinical Research Fellow, Institute of Cancer Research 

UKCGG National CGM Summary
(Mixed Cases) 
Meeting date: 17 December 2020 
 

A summary document of the UKCGG National Cancer Genetics MDT on the 17th of December 2020.Topic: Mixed Cases. 

UKCGG National CGM Presentation 
(Li-Fraumeni Syndrome and heritable TP53-related cancer (hTP53rc) syndrome)
Meeting date: 15 October 2020

Presentation slides from Dr Helen Hanson on behalf of UKCGG Council and CGCV. Patient Information Removed. 

UKCGG National CGM Attendee Ground Rules 
Last updated: 17 September 2020

This document summaries the attendee and presenter etiquette, along with information governance and clinical responsibility ground rules.

UKCGG National CGM Summary
(Clinical considerations of variant classification and reclassification) 
Meeting date: 11 February 2021

A summary document of the UKCGG National Cancer Genetics MDT meeting on 11th of February 2021. Topic: clinical considerations of variant classification and reclassification.

UKCGG National CGM Presentation
(BRCA reclassification cases) 
Meeting date: 11 February 2021
 

A summary document of the UKCGG National Cancer Genetics MDT on the 17th of December 2020. Topic: Mixed Cases. 

UKCGG National CGM Summary
(Li-Fraumeni Syndrome and heritable TP53-related cancer (hTP53rc) syndrome) 
Meeting date: 15 October 2020

A summary document of the first UKCGG National Cancer Genetics MDT on the15th of October 2020. Topic: Li-Fraumeni Syndrome and heritable TP53-related cancer (hTP53rc) syndrome.

 

UKCGG Website

GenETHICS Website

Contact Us